International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
May 14, 2021 at 04:01 pm EDT
International Stem Cell Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was USD 1.658 million compared to USD 2.360 million a year ago. Operating loss was USD 567,000 compared to USD 455,000 a year ago. Net loss was USD 599,000 compared to USD 373,000 a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.05 a year ago.